Transcriptional regulatory networks downstream of TAL1/SCL in T-cell acute lymphoblastic leukemia

Teresa Palomero, Duncan T. Odom, Jennifer O'Neil, Adolfo A. Ferrando, Adam Margolin, Donna S. Neuberg, Stuart S. Winter, Richard S. Larson, Wei Li, X. Shirley Liu, Richard A. Young, A. Thomas Look

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Aberrant expression of 1 or more transcription factor oncogenes is a critical component of the molecular pathogenesis of human T-cell acute lymphoblastic leukemia (T-ALL); however, oncogenic transcriptional programs downstream of T-ALL oncogenes are mostly unknown. TAL1/SCL is a basic helix-loop-helix (bHLH) transcription factor oncogene aberrantly expressed in 60% of human TALLs. We used chromatin immunoprecipitation (ChIP) on chip to identify 71 direct transcriptional targets of TAL1/SCL. Promoters occupied by TAL1 were also frequently bound by the class I bHLH proteins E2A and HEB, suggesting that TAL1/ E2A as well as TAL1/HEB heterodimers play a role in transformation of T-cell precursors. Using RNA interference, we demonstrated that TAL1 is required for the maintenance of the leukemic phenotype in Jurkat cells and showed that TAL1 binding can be associated with either repression or activation of genes whose promoters occupied by TAL1, E2A, and HEB. In addition, oligonucleotide microarray analysis of RNA from 47 primary T-ALL samples showed specific expression signatures involving TAL1 targets in TAL1-expressing compared with -nonexpressing human T-ALLs. Our results indicate that TAL1 may act as a bifunctional transcriptional regulator (activator and repressor) at the top of a complex regulatory network that disrupts normal T-cell homeostasis and contributes to leukemogenesis.

Original languageEnglish (US)
Pages (from-to)986-992
Number of pages7
JournalBlood
Volume108
Issue number3
DOIs
StatePublished - Aug 1 2006
Externally publishedYes

Fingerprint

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
T-cells
Gene Regulatory Networks
Oncogenes
T-Lymphoid Precursor Cells
Basic Helix-Loop-Helix Transcription Factors
Jurkat Cells
Chromatin Immunoprecipitation
RNA
Microarray Analysis
RNA Interference
Oligonucleotide Array Sequence Analysis
Transcriptional Activation
Microarrays
Homeostasis
Transcription Factors
Oligonucleotides
Maintenance
Chromatin
T-Lymphocytes

ASJC Scopus subject areas

  • Hematology

Cite this

Palomero, T., Odom, D. T., O'Neil, J., Ferrando, A. A., Margolin, A., Neuberg, D. S., ... Look, A. T. (2006). Transcriptional regulatory networks downstream of TAL1/SCL in T-cell acute lymphoblastic leukemia. Blood, 108(3), 986-992. https://doi.org/10.1182/blood-2005-08-3482

Transcriptional regulatory networks downstream of TAL1/SCL in T-cell acute lymphoblastic leukemia. / Palomero, Teresa; Odom, Duncan T.; O'Neil, Jennifer; Ferrando, Adolfo A.; Margolin, Adam; Neuberg, Donna S.; Winter, Stuart S.; Larson, Richard S.; Li, Wei; Liu, X. Shirley; Young, Richard A.; Look, A. Thomas.

In: Blood, Vol. 108, No. 3, 01.08.2006, p. 986-992.

Research output: Contribution to journalArticle

Palomero, T, Odom, DT, O'Neil, J, Ferrando, AA, Margolin, A, Neuberg, DS, Winter, SS, Larson, RS, Li, W, Liu, XS, Young, RA & Look, AT 2006, 'Transcriptional regulatory networks downstream of TAL1/SCL in T-cell acute lymphoblastic leukemia', Blood, vol. 108, no. 3, pp. 986-992. https://doi.org/10.1182/blood-2005-08-3482
Palomero, Teresa ; Odom, Duncan T. ; O'Neil, Jennifer ; Ferrando, Adolfo A. ; Margolin, Adam ; Neuberg, Donna S. ; Winter, Stuart S. ; Larson, Richard S. ; Li, Wei ; Liu, X. Shirley ; Young, Richard A. ; Look, A. Thomas. / Transcriptional regulatory networks downstream of TAL1/SCL in T-cell acute lymphoblastic leukemia. In: Blood. 2006 ; Vol. 108, No. 3. pp. 986-992.
@article{8c70142b2e4748a1bcad9ce539c60162,
title = "Transcriptional regulatory networks downstream of TAL1/SCL in T-cell acute lymphoblastic leukemia",
abstract = "Aberrant expression of 1 or more transcription factor oncogenes is a critical component of the molecular pathogenesis of human T-cell acute lymphoblastic leukemia (T-ALL); however, oncogenic transcriptional programs downstream of T-ALL oncogenes are mostly unknown. TAL1/SCL is a basic helix-loop-helix (bHLH) transcription factor oncogene aberrantly expressed in 60{\%} of human TALLs. We used chromatin immunoprecipitation (ChIP) on chip to identify 71 direct transcriptional targets of TAL1/SCL. Promoters occupied by TAL1 were also frequently bound by the class I bHLH proteins E2A and HEB, suggesting that TAL1/ E2A as well as TAL1/HEB heterodimers play a role in transformation of T-cell precursors. Using RNA interference, we demonstrated that TAL1 is required for the maintenance of the leukemic phenotype in Jurkat cells and showed that TAL1 binding can be associated with either repression or activation of genes whose promoters occupied by TAL1, E2A, and HEB. In addition, oligonucleotide microarray analysis of RNA from 47 primary T-ALL samples showed specific expression signatures involving TAL1 targets in TAL1-expressing compared with -nonexpressing human T-ALLs. Our results indicate that TAL1 may act as a bifunctional transcriptional regulator (activator and repressor) at the top of a complex regulatory network that disrupts normal T-cell homeostasis and contributes to leukemogenesis.",
author = "Teresa Palomero and Odom, {Duncan T.} and Jennifer O'Neil and Ferrando, {Adolfo A.} and Adam Margolin and Neuberg, {Donna S.} and Winter, {Stuart S.} and Larson, {Richard S.} and Wei Li and Liu, {X. Shirley} and Young, {Richard A.} and Look, {A. Thomas}",
year = "2006",
month = "8",
day = "1",
doi = "10.1182/blood-2005-08-3482",
language = "English (US)",
volume = "108",
pages = "986--992",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "3",

}

TY - JOUR

T1 - Transcriptional regulatory networks downstream of TAL1/SCL in T-cell acute lymphoblastic leukemia

AU - Palomero, Teresa

AU - Odom, Duncan T.

AU - O'Neil, Jennifer

AU - Ferrando, Adolfo A.

AU - Margolin, Adam

AU - Neuberg, Donna S.

AU - Winter, Stuart S.

AU - Larson, Richard S.

AU - Li, Wei

AU - Liu, X. Shirley

AU - Young, Richard A.

AU - Look, A. Thomas

PY - 2006/8/1

Y1 - 2006/8/1

N2 - Aberrant expression of 1 or more transcription factor oncogenes is a critical component of the molecular pathogenesis of human T-cell acute lymphoblastic leukemia (T-ALL); however, oncogenic transcriptional programs downstream of T-ALL oncogenes are mostly unknown. TAL1/SCL is a basic helix-loop-helix (bHLH) transcription factor oncogene aberrantly expressed in 60% of human TALLs. We used chromatin immunoprecipitation (ChIP) on chip to identify 71 direct transcriptional targets of TAL1/SCL. Promoters occupied by TAL1 were also frequently bound by the class I bHLH proteins E2A and HEB, suggesting that TAL1/ E2A as well as TAL1/HEB heterodimers play a role in transformation of T-cell precursors. Using RNA interference, we demonstrated that TAL1 is required for the maintenance of the leukemic phenotype in Jurkat cells and showed that TAL1 binding can be associated with either repression or activation of genes whose promoters occupied by TAL1, E2A, and HEB. In addition, oligonucleotide microarray analysis of RNA from 47 primary T-ALL samples showed specific expression signatures involving TAL1 targets in TAL1-expressing compared with -nonexpressing human T-ALLs. Our results indicate that TAL1 may act as a bifunctional transcriptional regulator (activator and repressor) at the top of a complex regulatory network that disrupts normal T-cell homeostasis and contributes to leukemogenesis.

AB - Aberrant expression of 1 or more transcription factor oncogenes is a critical component of the molecular pathogenesis of human T-cell acute lymphoblastic leukemia (T-ALL); however, oncogenic transcriptional programs downstream of T-ALL oncogenes are mostly unknown. TAL1/SCL is a basic helix-loop-helix (bHLH) transcription factor oncogene aberrantly expressed in 60% of human TALLs. We used chromatin immunoprecipitation (ChIP) on chip to identify 71 direct transcriptional targets of TAL1/SCL. Promoters occupied by TAL1 were also frequently bound by the class I bHLH proteins E2A and HEB, suggesting that TAL1/ E2A as well as TAL1/HEB heterodimers play a role in transformation of T-cell precursors. Using RNA interference, we demonstrated that TAL1 is required for the maintenance of the leukemic phenotype in Jurkat cells and showed that TAL1 binding can be associated with either repression or activation of genes whose promoters occupied by TAL1, E2A, and HEB. In addition, oligonucleotide microarray analysis of RNA from 47 primary T-ALL samples showed specific expression signatures involving TAL1 targets in TAL1-expressing compared with -nonexpressing human T-ALLs. Our results indicate that TAL1 may act as a bifunctional transcriptional regulator (activator and repressor) at the top of a complex regulatory network that disrupts normal T-cell homeostasis and contributes to leukemogenesis.

UR - http://www.scopus.com/inward/record.url?scp=33746656195&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746656195&partnerID=8YFLogxK

U2 - 10.1182/blood-2005-08-3482

DO - 10.1182/blood-2005-08-3482

M3 - Article

VL - 108

SP - 986

EP - 992

JO - Blood

JF - Blood

SN - 0006-4971

IS - 3

ER -